Position in EOLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$26,208,882
-$12,498,433 QoQ
Shares Held
6,376,857
+9.6% QoQ
Ownership
9.68%
of shares outstanding
% of Portfolio
1.58%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Derivatives in EOLS
reported options exposure · as of Jun 30, 2025CallValue
$921,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Nantahala Capital Management, LLC holds $159,502,303 across 10 Drug Manufacturers - Specialty & Generic names. EOLS ranks #3 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRX |
Amneal Pharmaceuticals, Inc.
|
2,844,108 | $35,352,262 | |
| 2 | ETON |
Eton Pharmaceuticals, Inc.
|
1,175,951 | $29,022,470 | |
| 3 | EOLS |
Evolus, Inc.
This page
|
6,376,857 | $26,208,882 | |
| 4 | ADCT |
ADC Therapeutics SA
|
5,597,433 | $20,990,373 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,987,397 | $18,920,019 | |
| 6 | ASRT |
Assertio Holdings, Inc.
|
692,335 | $13,195,905 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
535,684 | $7,446,007 | |
| 8 | AYTU |
Aytu Biopharma, Inc
|
1,086,812 | $2,966,996 |
All Filings in EOLS
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,208,882 | 6,376,857 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,707,315 | 5,820,649 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $35,162,901 | 5,726,857 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $38,662,898 | 4,197,926 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $921,000 | 100,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $1,203,000 | 100,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $43,925,656 | 3,651,343 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $34,556,844 | 3,130,149 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $45,762,553 | 2,824,849 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,582,711 | 2,910,849 | Shares | Sole | 2024-08-20 | |
| 2024-03-31 | $40,751,886 | 2,910,849 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $30,651,239 | 2,910,849 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $3,849,950 | 421,220 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||